摘要 |
<p>The present invention provides a novel intermediate for efficiently producing a 1β-methylcarbapenem compound for oral administration, and a process for producing the intermediate. That is, the present invention provides a process for producing a novel β-lactam compound represented by general formula (4), the process including allowing a β-lactam compound represented by general formula (5) as a starting material to react with a compound represented by general formula (6) in the presence of a base to obtain a novel β-lactam compound represented by general formula (1), protecting the hydroxyl group, subsequently performing cyclization in the presence of a strong base, allowing the cyclized compound to react with diphenylphosphoryl chloride to obtain a novel β-lactam compound represented by general formula (3), and eliminating the protecting group therefrom.<!-- EPO <DP n="8001"> --><Chemistry id="chema01" num="0001"><Image id="ia01" he="50" wi="152" file="IMGA0001.TIF" imgContent="chem" imgFormat="TIFF" /></Chemistry><Chemistry id="chema02" num="0002"><Image id="ia02" he="54" wi="146" file="IMGA0002.TIF" imgContent="chem" imgFormat="TIFF" /></Chemistry> (In the formulae, R<Sub>1</Sub> represents a trimethylsilyl group or a triethylsilyl group; R<Sub>2</Sub> represents an aryl group or a heteroaryl group; R<Sub>3</Sub> represents an alkyl group having 1 to 10 carbon atoms or a cycloalkyl group having 3 to 10 carbon atoms; and X represents a halogen atom.)</p> |